Adimmune (TPE:4142) E10: NT$-1.04 (As of Dec. 2025)


TPE:4142 Adimmune Corp TPE:4142
55 GF Score
Price NT$16.80
GF Value NT$25.40
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Adimmune E10?

Adimmune TPE:4142 -1.75% 55 E10 is NT$-1.04 as of Dec. 2025. GuruFocus rates TPE:4142 with a GF Score™ of 55/100 and a GF Value™ of NT$25.40 (Possible Value Trap). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Adimmune's adjusted earnings per share data for the three months ended in Dec. 2025 was NT$0.520. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is NT$-1.04 for the trailing ten years ended in Dec. 2025.

During the past 3 years, the average E10 Growth Rate was 17.30% per year. During the past 5 years, the average E10 Growth Rate was 14.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Adimmune was 17.30% per year. The lowest was 11.40% per year. And the median was 14.60% per year.

As of today (2026-06-28), Adimmune's current stock price is NT$16.80. Adimmune's E10 for the quarter that ended in Dec. 2025 was NT$-1.04. Adimmune's Shiller PE Ratio of today is .


Adimmune  (TPE:4142) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Adimmune E10 Related Terms


Adimmune E10 Historical Data

* Premium members only.

The historical data trend for Adimmune's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adimmune E10 Chart

Adimmune Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.20 -1.84 -1.65 -1.37 -1.04

Adimmune Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.37 -1.36 -1.37 -1.28 -1.04

TPE:4142 vs VRTX, REGN, ALNY: E10 Comparison

For the Biotechnology subindustry, Adimmune's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adimmune Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adimmune's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Adimmune's Shiller PE Ratio falls into.


TPE:4142
55GF Score
Adimmune Corp TPE:4142
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adimmune E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Adimmune's adjusted earnings per share data for the three months ended in Dec. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=0.52/324.0540*324.0540
=0.520

Current CPI (Dec. 2025) = 324.0540.

Adimmune Quarterly Data

per share eps CPI Adj_EPS
201603 -0.598 238.132 -0.814
201606 -0.427 241.018 -0.574
201609 -0.522 241.428 -0.701
201612 -0.864 241.432 -1.160
201703 -0.797 243.801 -1.059
201706 -0.598 244.955 -0.791
201709 -0.456 246.819 -0.599
201712 -1.225 246.524 -1.610
201803 -0.722 249.554 -0.938
201806 -0.330 251.989 -0.424
201809 -0.030 252.439 -0.039
201812 -1.510 251.233 -1.948
201903 -0.830 254.202 -1.058
201906 -0.620 256.143 -0.784
201909 0.310 256.759 0.391
201912 -0.020 256.974 -0.025
202003 -0.050 258.115 -0.063
202006 -0.350 257.797 -0.440
202009 0.380 260.280 0.473
202012 3.028 260.474 3.767
202103 -0.580 264.877 -0.710
202106 -0.380 271.696 -0.453
202109 0.370 274.310 0.437
202112 0.690 278.802 0.802
202203 -0.550 287.504 -0.620
202206 0.110 296.311 0.120
202209 0.980 296.808 1.070
202212 0.140 296.797 0.153
202303 -0.590 301.836 -0.633
202306 -0.570 305.109 -0.605
202309 0.630 307.789 0.663
202312 -0.980 306.746 -1.035
202403 -0.440 312.332 -0.457
202406 -0.650 314.175 -0.670
202409 0.620 315.301 0.637
202412 -0.120 315.605 -0.123
202503 -0.530 319.799 -0.537
202506 -0.520 322.561 -0.522
202509 -0.040 324.800 -0.040
202512 0.520 324.054 0.520

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of NT$-1.04 mean?
Adimmune (TPE:4142) has a E10 of NT$-1.04 as of Dec. 2025. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Adimmune and its competitors.
Is Adimmune's E10 too high?
Adimmune's current E10 is NT$-1.04. Overall, Adimmune has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Adimmune's E10 compare to VRTX and REGN?
Adimmune's E10 of NT$-1.04 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Adimmune and its competitors. Adimmune's current E10 is NT$-1.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adimmune stock overvalued right now?
Based on GuruFocus' analysis, Adimmune (TPE:4142) is currently considered Possible Value Trap. The stock's GF Value™ is NT$25.40, compared to a current price of NT$16.80 — trading 33.9% below its estimated fair value. The current E10 is NT$-1.04. Adimmune's overall GF Score™ is 55/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Adimmune (TPE:4142), the current E10 is NT$-1.04 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Adimmune (TPE:4142) Overvalued in 2026?

Based on GuruFocus' analysis, Adimmune stock appears to be undervalued. The current stock price of NT$16.80 is trading 33.9% below its estimated GF Value™ of NT$25.40. GuruFocus considers Adimmune to be Possible Value Trap.

Key valuation signals for TPE:4142:

  • E10: NT$-1.04
  • GF Value™: NT$25.40 vs. price of NT$16.80 (33.9% below fair value)
  • GF Score™: 55/100 with 6 warning signs

No single metric tells the full story. See the TPE:4142 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Adimmune Business Description

Address Tanxing Road, No. 3, Section 1, Tanzi District, Taichung City, TWN, 427003
Adimmune Corp is engaged in the research and development, processing, manufacturing, and trading of serum, vaccines, testing reagents, biologicals, and other bacterial fluids, as well as western medicines, animal medicines, chemicals, and feed additives. Its segments are separated by business as Adimmune Corporation, which generates maximum revenue and is engaged in the manufacturing of influenza vaccines with EU GMP and US FDA certificates in Taiwan. Its products include Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine, Influenza A (H1N1) Virus Monovalent Vaccine, and others, and Enimmune Corporation. The Group's revenue is mainly from the manufacturing and trading of vaccines, modern medicine products and testing reagents, as well as entrusted packing of vaccines.
55GF Score

Get the complete analysis for TPE:4142

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$16.80
Price
NT$25.40
GF Value